SU HYUN KIM: Open Payments
NPI 1942866199 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 10 payments from 6 companies in 2025. Trend: 2023 $152 · 2024 $482 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: INGREZZA, COBENFY, INVEGA SUSTENNA, REXULTI, VRAYLAR, AUSTEDO XR.
Industry payments across LA — which companies pay providers there.
